Encorium Group News (NASDAQ:ENCO)
| Latest Encorium Group News Headlines | | Date | Time | Source | | | 09/22/2008 | 7:31AM | PRNUS | Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
Approximately $20 Million of New Business Contracts Announced During the Past Ten Weeks
WAYNE, Penn., Sept. 22 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full-service multinational contract research organization (CRO) that provides design, development, and management capabilities for clinical trials... More...>> |
| 09/22/2008 | 7:30AM | PRNUS | Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regar
WAYNE, Penn., Sept. 22 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that at this time Encorium and Prologue... More...>> |
| 09/10/2008 | 5:50PM | PRNUS | Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors
Company to hold Conference Call Thursday, September 11 at 11:00 AM ET
WAYNE, Pa., Sept. 10 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology... More...>> |
| 09/09/2008 | 5:33PM | PRNUS | Prologue Acquisition Update and Termination of Linkcon Business Combination
WAYNE, Pa., Sept. 9 /PRNewswire-FirstCall/ -- Encorium Group, Inc. (NASDAQ:ENCO), a full service multinational clinical research organization (CRO) conducting studies in over 30 countries for many of the world's leading pharmaceutical and biotechnology companies, today announced that it has entered into an amendment... More...>> |
| 06/19/2007 | 8:47AM | PRNUS | Oramed Pharmaceuticals Signs Agreement with Encorium Group to Commence Investigational New Drug Application
JERUSALEM and WAYNE, Pa., June 19 /PRNewswire-FirstCall/ -- Oramed Pharmaceuticals, Inc.(OTC:ORMP) (BULLETIN BOARD: ORMP) , an Israeli company focused on the development of oral delivery solutions based on proprietary technology and Encorium Group, Inc. (NASDAQ:ENCO), an international full service contract research... More...>> |
|
|
|